Kymera Therapeutics (NASDAQ:KYMR) Shares Gap Up on Insider Buying Activity

Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Free Report) shares gapped up prior to trading on Tuesday after an insider bought additional shares in the company. The stock had previously closed at $14.40, but opened at $15.30. Kymera Therapeutics shares last traded at $15.59, with a volume of 99,077 shares traded. Specifically, Director Bvf Partners L. […]

Related Keywords

Leerink Partnrs ,Piper Sandler ,Stifel Nicolaus ,Kymera Therapeutics Inc ,Dimensional Fund Advisors ,Nasdaq ,Securities Exchange Commission ,Metlife Investment Management ,Blackrock Inc ,Morgan Stanley ,York Mellon Corp ,Kymera Therapeutics ,Get Free Report ,Director Bvf Partners ,Exchange Commission ,New York Mellon Corp ,Life Investment Management ,Fund Advisors ,Kymera Therapeutics Daily ,Nasdaq Kymr ,Kymr ,Medical ,Stocks ,Technicals ,